Wistron Medical Technology, in collaboration with Taipei Medical University (TMU), is conducting clinical trials at TMU-affiliated hospitals. The TMU medical team and Wistron’s engineering team are working together to continuously monitor and analyze the physiological values of patients during hemodialysis using BestShape VS. Based on data from over 1600 patients, the team has built a preliminary AI model, hoping to proactively identify potential symptoms and expand its applications in the future. In the complex process of hemodialysis treatment, BestShape VS can assist medical staff in early intervention, thereby reducing or avoiding acute complications.
The Wistron R&D team, led by TMU President Wu Mai-si, along with Assistant Professor Tsai Cheng-yu of the College of Biomedical Engineering at TMU and Dr. Liao Chia-te, Director of the Department of Nephrology at Shuang Ho Hospital, are conducting research on the health monitoring of hemodialysis patients. Starting with Shuang Ho Hospital, cross-disciplinary verification and system integration testing were conducted, and the program has now expanded to affiliated hospitals within the system, including Taipei Medical University Hospital, Wan Fang Hospital, and Shin Kong Min Hospital.
Currently, during hemodialysis treatment, patients are not equipped with devices capable of continuously monitoring physiological values, and blood pressure needs to be measured while undergoing dialysis, which is not only inconvenient but also quite uncomfortable. Wistron Medical Technology’s independently developed and manufactured BestShape VS utilizes millimeter-wave non-contact technology to continuously monitor the physiological values and sleep patterns of lying patients for extended periods without disturbing them, providing comfortable and real-time monitoring services and offering considerate care for patients undergoing hemodialysis.
Successful hemodialysis treatment relies on multi-party collaboration. Wistron Medical Technology Chairman Huang Chun-tung pointed out that by combining clinical observation and BestShape VS radar technology, the team has developed and trained appropriate models with different parameters to detect changes in respiratory and heart rate, patterns, and their coupling in real time. This allows for the prediction of conditions such as low blood pressure, cramps, and excessive dehydration during hemodialysis treatment. Future applications are expected to extend to assessing the risk of heart failure in hemodialysis patients. This will not only help build a safe hemodialysis treatment environment but also enable early detection of potential patient problems, laying a solid foundation for subsequent diverse medical research and applications.
Through this collaboration with Taipei Medical University, Wistron Medical Technology’s BestShape VS will continue to deepen the AI early warning function of precision medical devices, exploring the correlation between physiological parameters and potential diseases. In addition to the hemodialysis center in the nephrology department, future expansion will extend to other wards or home care for patients to help them coexist with their illness and improve their quality of life after dialysis treatment.
Wistron Medical Technology and Taipei Medical University will work together to take smart healthcare services to the next level.